Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prospective Randomized Trial
100%
Antimicrobial Therapy
100%
Infectious Keratitis
100%
Randomized Phase III Trial
100%
PACK-CXL
100%
Treatment Lines
28%
Israel
14%
China
14%
No Significant Difference
14%
Healing
14%
Iran
14%
Inflammatory Process
14%
Treatment Group
14%
Trial Registration
14%
Phase I Trial
14%
Antimicrobial
14%
India
14%
Success Rate
14%
Timing Analysis
14%
Treatment Efficacy
14%
Lost to Follow-up
14%
Re-epithelialization
14%
Therapy Groups
14%
Treatment Failure
14%
Photoactivation
14%
Egypt
14%
Anterior Chamber
14%
Chromophore
14%
Complete Resolution
14%
Mixed Origin
14%
Corneal Cross-linking
14%
American Academy of Ophthalmology
14%
Global Blindness
14%
Corneal Re-epithelialization
14%
Alternative Antibiotics
14%
Corneal Epithelial Defect
14%
Epithelialization Period
14%
Standalone Treatment
14%
Medicine and Dentistry
Antimicrobial Therapy
100%
Keratitis
100%
Epithelization
60%
Infection
20%
Clinical Trial
20%
Antiinfective Agent
20%
Cross-Link
20%
Group Therapy
20%
Skin Defect
20%
Ophthalmology
20%
Anterior Chamber of Eyeball
20%
Treatment Group
20%
Nursing and Health Professions
Antimicrobial Therapy
100%
Keratitis
100%
Infection
20%
Practice Guideline
20%
Treatment Failure
20%
Antiinfective Agent
20%
Skin Defect
20%
Treatment Group
20%
Clinical Trial
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antimicrobial Therapy
100%
Keratitis
100%
Antiinfective Agent
40%
Infection
20%
Clinical Trial
20%
Skin Defect
20%
Treatment Group
20%
Immunology and Microbiology
Keratitis
100%
Epithelization
60%
Cross Linking
20%
Infectious Disease
20%
Infection
20%